Page 24 - Mobile Android News Today

SAN DIEGO — Although endoscopic submucosal dissection continues to gain ground in managing colorectal laterally spreading lesions, endoscopic mucosal resection maintains a critical role, according to a debate at Digestive Diseases Week. “The debate today perhaps should not be about EMR vs. ESD, but instead our quest for ideal endoscopic resection,” Dennis Yang, MD, director of

A recently published survey revealed that nearly half of American workers report they and their coworkers are more acutely aware of stress than they were before the COVID-19 pandemic.In a company press release, LifeWorks Mental Health Index reported that 42% of U.S. citizens who felt more sensitive to stressors recorded a mental health score more than 10 points below the national average. In

SAN DIEGO — Minimal long-term cardiac safety findings were reported with ozanimod treatment in patients with ulcerative colitis and relapsing multiple sclerosis, according to research presented at Digestive Disease Week 2022. “Ozanimod is a newly approved, oral sphingosine-1-phosphate (S1P) receptor modulator that specifically targets S1P1 and S1P5 and prevents lymphocyte migration

SAN FRANCISCO — Results presented here showed anatomic-based medial collateral ligament repair and MCL reconstruction may be equivalent based on objective knee laxity, but MCL reconstruction had better subjective outcomes. Nicholas N. DePhillipo, PhD, ATC, and colleagues randomly assigned 54 patients with grade 3 MCL tears with or without concomitant ACL injuries to undergo either an

SAN DIEGO — Statin therapy decreased the risk for developing acute cholangitis among patients with primary sclerosing cholangitis, according to research presented at Digestive Disease Week 2022. “Primary sclerosing cholangitis [PSC] is a cholestatic biliary disease whose analysis and underlying biology remains fairly poorly understood,” Chiraag Kulkarni, MD, internal

Delaying or stopping STEMI treatment during the first COVID-19-related lockdown in England was associated with approximately 2 life-years lost per patient vs. pre-lockdown conditions, according to a modeling analysis presented at EuroPCR.In an analysis to predict the potential clinical and economic burden associated with reductions in PCI treatment access during the COVID-19 lockdown in England,

Peer-reviewed papers on pediatric antiphospholipid syndrome do not appear very often.However, when they do, they can be incredibly useful for rheumatologists who find themselves trying to diagnose and manage a patient with this rare and complicated condition, which can present in myriad ways.

The FDA has granted De Novo authorization for NeuroMetrix to market its Quell neuromodulation device as an aid for reducing fibromyalgia symptoms in adults with high pain sensitivity, according to a company press release.“There is an unmet need for effective and safe fibromyalgia treatments,” Shai N. Gozani, MD, PhD, CEO of NeuroMetrix, said in the release. “Receiving this De

ATLANTA – A no-implant interatrial shunt improved HF symptoms including exercise capacity, quality of life and NYHA class at 3 and 6 months, a speaker reported.At the Society for Cardiovascular Angiography and Interventions Scientific Sessions, Colin M. Barker, MDI, FSCAI, director of the cardiac catheterization laboratory at Vanderbilt University Medical Center in Nashville, Tennessee,

The National Kidney Foundation announced it has entered a partnership with the American Society of Transplantation’s Living Donor Circle of Excellence program.According to a press release, the Circle of Excellence is designed to increase the number living organ donors by acknowledging employers that supply lost wages while donors recover from surgery. To join the Circle of Excellence,